- Home
- PRFX vs AKAN Comparison
PRFX vs AKAN Comparison
Compare PRFX & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRFX
- AKAN
- Stock Information
- Founded
- PRFX 2007
- AKAN 2021
- Country
- PRFX Israel
- AKAN Canada
- Employees
- PRFX N/A
- AKAN N/A
- Industry
- PRFX Biotechnology: Pharmaceutical Preparations
- AKAN Medicinal Chemicals and Botanical Products
- Sector
- PRFX Health Care
- AKAN Health Care
- Exchange
- PRFX Nasdaq
- AKAN Nasdaq
- Market Cap
- PRFX 2.9M
- AKAN 3.2M
- IPO Year
- PRFX 2020
- AKAN 2022
- Fundamental
- Price
- PRFX $1.40
- AKAN $1.33
- Analyst Decision
- PRFX Hold
- AKAN
- Analyst Count
- PRFX 1
- AKAN 0
- Target Price
- PRFX N/A
- AKAN N/A
- AVG Volume (30 Days)
- PRFX 326.0K
- AKAN 68.5K
- Earning Date
- PRFX 08-14-2025
- AKAN 07-22-2025
- Dividend Yield
- PRFX N/A
- AKAN N/A
- EPS Growth
- PRFX N/A
- AKAN N/A
- EPS
- PRFX N/A
- AKAN N/A
- Revenue
- PRFX N/A
- AKAN $836,664.00
- Revenue This Year
- PRFX N/A
- AKAN N/A
- Revenue Next Year
- PRFX N/A
- AKAN N/A
- P/E Ratio
- PRFX N/A
- AKAN N/A
- Revenue Growth
- PRFX N/A
- AKAN 97.47
- 52 Week Low
- PRFX $1.25
- AKAN $0.93
- 52 Week High
- PRFX $16.63
- AKAN $4.82
- Technical
- Relative Strength Index (RSI)
- PRFX 35.72
- AKAN 49.68
- Support Level
- PRFX $1.25
- AKAN $1.25
- Resistance Level
- PRFX $1.44
- AKAN $1.49
- Average True Range (ATR)
- PRFX 0.10
- AKAN 0.11
- MACD
- PRFX 0.01
- AKAN -0.00
- Stochastic Oscillator
- PRFX 50.00
- AKAN 43.86
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.